SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Forecast, Price Target & Analyst Ratings
TSX-V:SVA • CA81752F1062
0.165 CAD
-0.01 (-2.94%)
Last: Mar 10, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SERNOVA BIOTHERAPEUTICS INC (SVA.CA).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateFeb 7, 2022
PeriodQ2 / 2022
EPS Estimate-$0.01
Revenue Estimate
ChartMill Buy Consensus
83.64%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$0.17 to mean target of N/A, Based on 11 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
83.64%
SVA.CA was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SVA.CA.
In the previous month the buy percentage consensus was at a similar level.
SVA.CA was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-11-18 | HC Wainwright | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateFeb 7, 2022
PeriodQ2 / 2022
EPS Estimate-$0.01
Revenue Estimate
Revenue Q2QN/A
EPS Q2QN/A
Number of Analysts4
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
SVA.CA is expected to report earnings on 2/7/2022. The consensus EPS estimate for the next earnings is -0.01 CAD and the consensus revenue estimate is 0 CAD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | ||||||||
| EBITDA YoY % growth | -2.389M | -2.494M -4.41% | -2.604M -4.39% | -3.65M -40.19% | -3.95M -8.22% | -5.03M -27.34% | -6.67M -32.60% | N/A -123.14% | N/A -88.24% | N/A -4.04% | N/A 36.51% | N/A 17.30% | |
| EBIT YoY % growth | -2.886M | -2.502M 13.31% | -2.643M -5.67% | -3.71M -40.35% | -4.01M -8.09% | -5.26M -31.17% | -6.94M -31.94% | N/A -92.94% | N/A -100.00% | N/A -26.92% | N/A 64.53% | N/A 63.46% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 50.00% | N/A -50.00% | N/A -366.67% | N/A -28.57% | N/A 33.33% | N/A 0.60% | N/A -2.38% |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.01 | -0.02 | -0.02 -106.00% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | -2.884M -84.87% | -4.017M -175.14% | -5.253M -139.86% |
| EBIT Q2Q % growth | N/A | N/A | N/A |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
SERNOVA BIOTHERAPEUTICS INC / SVA.CA Forecast FAQ
When does SERNOVA BIOTHERAPEUTICS INC (SVA.CA) report earnings?
SERNOVA BIOTHERAPEUTICS INC (SVA.CA) will report earnings on 2022-02-07.
What are the consensus estimates for SVA stock next earnings?
The consensus EPS estimate for the next earnings of SERNOVA BIOTHERAPEUTICS INC (SVA.CA) is -0.01 CAD and the consensus revenue estimate is 0 CAD.
How many analysts have analysed SERNOVA BIOTHERAPEUTICS INC (SVA.CA)?
The number of analysts covering SERNOVA BIOTHERAPEUTICS INC (SVA.CA) is 11.